Microsoft Word - Savient Update on KRYSTEXXA BLA Filingdoc - Biologic - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2016-07-11 17:00:04 Clinical research Food and Drug Administration Pharmaceutical industry Drug safety Savient pharmaceuticals Pharmaceuticals policy Pegloticase Biologic license application PEGylation Validation Pharmacovigilance Clinical trial		Microsoft Word - Savient Update on KRYSTEXXA BLA Filingdoc Add to Reading List Source URL: www.mvpharm.com Download Document from Source Website File Size: 40,14 KB Share Document on Facebook

	Microsoft Word - Savient Resubmits Biologics License Application for KRYSTEXXAdoc DocID: 1qqBA - View Document
	Microsoft Word - Savient Update on KRYSTEXXA BLA Filingdoc DocID: 1ot1g - View Document
	PDF Document DocID: 16eHM - View Document
	BLA Complete Response Letter DocID: 14Ctf - View Document
	DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Silver Spring MD[removed]MEMORANDUM Date: DocID: XoPt - View Document